This section offers content specifically designed for physicians and other healthcare professionals wishing to learn and share experiences with pituitary disease.
From the desk of PWN cofounder Lewis S. Blevins Jr. M.D. – I’ve always been fascinated with the history of medicine. It’s one of the things that led me to this profession in the first
From the desk of Lewis S. Blevins, Jr. M.D. PWN cofounder – Idiopathic isolated central adrenal insufficiency remains a mystery. I’ve seen several patients with this condition in my career. I first learned about it
We are please to help with the distribution of this Healthcare Professional Survey on AVP-Deficiency. If you are HCP please participate in this important initiative. There are five short sections and you will only be
In what he calls his passion in an ever-evolving field, world renowned neurosurgeon, Dr. Sandeep Kunwar presents a rational approach for the management of Craniopharyngiomas. He focuses on all aspects of this procedure.
This excerpt from our presentation on pituitary surgery focuses on surgery in the cavernous sinus and procedure issues, benefits, and risks.
A pituitary radiologist shares key rules and insights to improve diagnosis and collaboration in patient care.
For more details and registration click here Overview This course provides endocrinologists, neurosurgeons, and other providers who care for patients with pituitary disorders with a review and update of the more controversial encountered problems in
Episode 3 of Pituitary Grand Rounds explores cortisol disorders tied to adrenal issues and diagnostic challenges.
The latest news from Corcept Therapeutics on their Phase 3 GRACE clinical trial clinical trial is excellent. The drug relacorilant significantly reduced high blood pressure and blood sugar levels in people with endogenous Cushing’s syndrome.
Podcast and Video: In today’s podcast and accompanying video, Dr. Blevins discusses and illustrates the case of a patient with a double pituitary adenoma.
From J D Faccinetti, chief editor co-founder – First, some background: the latest edition of the WHO (World Health Organization) Endocrine Tumors and Central Nervous System Tumors group reclassified pituitary adenomas as neuroendocrine tumors or
From Lewis S Blevins, Jr. M.D. – Long-term follow-up of patients with pituitary disorders is essential for many reasons. Firstly, those patients who have been rendered disease-free are always at risk for recurrence. While long-term